FIRST DAY
Wednesday. Sep 27, 2023
13.25-13.30 pm - OpeningWelcome and introduction: Pr Eric Deutsch,
Director of Gustave Roussy Radiation Oncology Department and INSERM UMR 1030PRIMER ON CANCER IMMUNOLOGY, RADIATIONS AND IMMUNOTHERAPY
Educational SessionSECOND DAY
Thursday. Sep 28, 2023
8.30-10.00 Session I: DNA DAMAGE RESPONSE
10.30-12.30 Session II: MYELOID CELLS
14.00-16.00: Session III: RT DOSE AND MODALITIES
16.30-18.00 Session IV: IMMUNOSUPPRESSION
THIRD DAY
Friday. Sep 29, 2023
8.30-10.00 Session V: TUMOR MICROENVIRONMENT
10.30-12.30 Session VI: AI, IMAGING AND RADIOMICS
14.00-16.00 Session VII: ADAPTIVE IMMUNITY
16.30-17.30 Session VIII: INNATE IMMUNITY
ABOUT THE MEETING
The clinical management of cancer is being revolutionized by agents that activate the immune system against the tumor. Nevertheless, many of these therapies benefit only to a minority of patients. In this context, radiotherapy is holding great promises as a means to complement immunotherapy in the management of malignant disorders. In particular, radiotherapy can generate an “in situ vaccination” effect that is at the foundation of optimal immune responses against cancer cells. Thus, the clinical potential of combining immunotherapy with radiotherapy is extraordinary.
Twitter Feeds
Tweets by immunorad2023
Download TELEGRAM and follow the news of the conference.
At the end of the day exchange comments with subscribers, interact and share your ideas.
Conference broadcast channel
Exchange channel
